Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: Evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol)

Haemophilia

Volumn 14, Issue SUPPL. 6, 2008, Pages 36-44

  Querol, F ^a,b   Cortina, V ^a   Cid, A R ^a   Haya, S ^a   Aznar, J A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Haemophilia; Inhibitors; Ultrasound

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTHRALGIA; ARTICLE; BIOLOGICAL ACTIVITY; BLEEDING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; HEMARTHROSIS; HEMOPHILIA; HUMAN; JOINT DEGENERATION; JOINT MOBILITY; PRIORITY JOURNAL; QUALITY OF LIFE;

ADOLESCENT; ADULT; ARTHRALGIA; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; EUROPE; FACTOR VIIA; HEMARTHROSIS; HEMOPHILIA A; HUMANS; QUALITY OF LIFE; RANGE OF MOTION, ARTICULAR; RECOMBINANT PROTEINS; TIME FACTORS; YOUNG ADULT;

EID: 53249087946     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01888.x     Document Type: Article

References (27)

1. Rodríguez-Merchán EC, Lee CA. Inhibitors in Patients with Haemophilia. Oxford, UK: Blackwell Science Ltd, 2002.
2. Morfini M, Auerswald G, Kobelt RA et al. Prophylactic treatment of haemophilia patients with inhibitors: Clinical experience with recombinant factor VIIa in European Haemophilia Centres. Haemophilia 2007; 13: 502-7.
3. Morfini M, Haya S, Tagariello G et al. European Study on Orthopaedic Status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
4. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006; 12: 117-21.
5. Morfini M, Haya S, Pollmann H et al. European Study on Orthopedic Status (ESOS) of haemophilia patients with inhibitors: Preliminary observations. Haemophilia 2006; 12: 64.
6. Morfini M, Haya S, Pollmann H et al. Preliminary observations from the European Study on Orthopaedic Status (ESOS) in hemophilia patients with Inhibitors. Blood (ASH Annual Meeting Abstracts) 2006; 108: 1037.
7. Manco-Johnson MJ. Update on treatment regimens: Prophylaxis versus on-demand therapy. Semin Hematol 2003; 40 (Suppl. 3): 3-9.
8. Manco-Johnson MJ, Abshire TC, Brown D et al. Initials results of a randomized, prospective trial of prophylaxis to prevent joint disease in young children with factor VIII deficiency. Blood (ASH Annual Meeting Abstracts) 2005; 106: 3.
9. Querol F, Aparisi F, Cid AR, Haya S, Cortina V, Aznar JA. Echographic evaluation of haemarthrosis in inhibitor hemophilic patients treated with rFVIIa (Preliminary report). Proceedings of 10th Musculoskeletal Congress World Federation of Hemophilia, Stresa, Italy, May 2007: 19.
10. Gilbert MS. Prophylaxis: Musculoskeletal evaluation. Semin Haematol 1993; 30: 3-6.
11. Manco-Johnson MJ, Nuss R, Funk S, Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000; 6: 649-57.
12. Hacker MR, Funk SM, Manco-Johnson MJ. The Colorado Haemophilia Paediatric Joint Physical Examination Scale: Normal values and interrater reliability. Haemophilia 2007; 13: 71-8.
13. Hilliard P, Funk S, Zourikian N et al. Hemophilia joint health score reliability study. Haemophilia 2006; 12: 518-25.
14. Querol F, Almendáriz A, López C et al. Guía de Rehabilitación en Hemofilia. Barcelona, Spain: Baxter, 2001.
15. Querol F. Criterios de exploración clínica en la artropatía hemofílica. Haematologica (Spanish edition) 2005; 90: 23-31.
16. Pettersson H. Radiographic scores and implications. Semin Hematol 1993; 30 (Suppl. 2): 7-9.
17. Cifrian C, Aparisi F. Evaluación de la artropatía hemofílica: Nuevos criterios radiológicos. Haematologica (Spanish edition) 2005; 90: 32-9.
18. Zukotynski K, Jarrin J, Babyn PS et al. Sonography for assessment of haemophilic arthropathy in children: A systematic protocol. Haemophilia 2007; 13: 293-304.
19. Greene WB, Heckman JD. Evaluación Clínica del Movimiento Articular. Barcelona: Edika Med, 1997.
20. Royer A, Cecconello R. Exploración articular y goniométrica. Generalidades. Encycl Méd Chir (Elsevier, Paris) Kinesiterapia y Medicina Física 2004; 26008-A-10.
21. Soucie JM, Cianfrini C, Janco RL et.al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 2004; 103: 2467-73.
22. Schiltz JP, Péninou G, Pineau JC, Digonnet B. Validation de la mesure périmétrique des membres inférieurs étude de la reproductibilitéde la mesure. Kinésithérapie Ann 2005; 48: 25-30.
23. McNally EG. Ultrosonografía Musculoesquelética. Madrid: Marbán, 2006.
24. Van Holsbeek MT, Introcaso JH. Ecografía Musculoesquelética. Madrid: Marban, 2006.
25. Jiménez JF. Ecografía en Traumatología del Deporte. Madrid: Marbán, 2007.
26. Rodríguez-Merchán EC, Goddard NJ, Lee CA. Musculoskeletal Aspects of Haemophilia. Oxford, UK: Blackwell Sciencie Ltd, 2000.
27. Rodríguez-Merchán EC. The Haemophilic Joints New Perspectives. Oxford, UK: Blackwell Science Ltd, 2003.